摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-<2-deoxy-β-D-erythro-pentofuranosyl>-3H-imidazo<4,5-b>pyridine | 125178-07-6

中文名称
——
中文别名
——
英文名称
3-<2-deoxy-β-D-erythro-pentofuranosyl>-3H-imidazo<4,5-b>pyridine
英文别名
3-(2-deoxy-β-D-erythro-pentofuranosyl)-3H-imidazo<4,5-b>pyridine;9-(2-deoxy-β-D-ribofuranosyl)-1-deazapurine;1-deazapurine β-2'-deoxyribonucleozide;3-(2-deoxy-β-D-erythro-pentofuranosyl)-3H-imidazo[4,5-b]pyridine;(2R,3S,5R)-2-(hydroxymethyl)-5-imidazo[4,5-b]pyridin-3-yloxolan-3-ol
3-<2-deoxy-β-D-erythro-pentofuranosyl>-3H-imidazo<4,5-b>pyridine化学式
CAS
125178-07-6
化学式
C11H13N3O3
mdl
——
分子量
235.243
InChiKey
CFUZUDJNRCIKSC-IVZWLZJFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    80.4
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:b0679e33cbe3351029bb36c4a13aef23
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-<2-deoxy-β-D-erythro-pentofuranosyl>-3H-imidazo<4,5-b>pyridine 在 recombinant Drosophila melanogaster kinase 、 5’-三磷酸腺苷 、 magnesium chloride 作用下, 以 various solvent(s) 为溶剂, 生成 Phosphoric acid mono-((2R,3S,5R)-3-hydroxy-5-imidazo[4,5-b]pyridin-3-yl-tetrahydro-furan-2-ylmethyl) ester
    参考文献:
    名称:
    非天然核苷的酶促磷酸化
    摘要:
    为了扩大遗传字母表,已经开发了许多非天然的、主要是疏水性的核苷类似物,它们在双链 DNA 中和酶促合成过程中选择性地配对。在含有这些碱基对的 DNA 的体外有效复制方面取得了重大进展。然而,基因字母表的体内扩展将要求非天然三磷酸核苷在细胞内以足够的浓度用于 DNA 复制。我们报告了我们为开发基于核苷补救酶的非自然体内核苷磷酸化途径所做的初步努力。该途径的第一步由黑腹果蝇核苷激酶催化,该激酶催化核苷磷酸化为相应的单磷酸酯。
    DOI:
    10.1021/ja028050m
  • 作为产物:
    参考文献:
    名称:
    6-取代的1-脱氮嘌呤2'-脱氧核糖核苷的合成
    摘要:
    描述了6-取代的1-脱氮嘌呤2'-脱氧核糖核苷的合成。1-脱氮嘌呤(咪唑并[4,5-的糖基化b与α-d-halogenose]吡啶)阴离子5给出了立体选择性Ñ 7 -和Ñ 9 -区域异构体。1个H-NMR和NOE 13 C-NMR光谱法被用于异构体的明确分配,和15的N- NMR化学位移与σ相关段哈米特常数和点电荷。
    DOI:
    10.1002/hlca.19960790117
点击查看最新优质反应信息

文献信息

  • Synthesis of 2-Deoxy-β-D-ribonucleosides and 2,3-Dideoxy-β-D-pentofuranosides on Immobilized Bacterial Cells
    作者:Ivan Votruba、Antonín Holý、Hana Dvořáková、Jaroslav Günter、Dana Hocková、Hubert Hřebabecký、Tomas Cihlar、Milena Masojídková
    DOI:10.1135/cccc19942303
    日期:——

    Alginate gel-entrapped cells of auxotrophic thymine-dependent strain of E. coli catalyze the transfer of 2-deoxy-D-ribofuranosyl moiety of 2'-deoxyuridine to purine and pyrimidine bases as well as their aza and deaza analogs. All experiments invariably gave β-anomers; in most cases, the reaction was regiospecific, affording N9-isomers in the purine and N1-isomers in the pyrimidine series. Also a 2,3-dideoxynucleoside can serve as donor of the glycosyl moiety. The acceptor activity of purine bases depends only little on substitution, the only condition being the presence of N7-nitrogen atom. On the other hand, in the pyrimidine series the activity is limited to only a narrow choice of mostly short 5-alkyl and 5-halogeno uracil derivatives. Heterocyclic bases containing amino groups are deaminated; this can be avoided by conversion of the base to the corresponding N-dimethylaminomethylene derivative which is then ammonolyzed. The method was verified by isolation of 9-(2-deoxy-β-D-ribofuranosyl) derivatives of adenine, guanine, 2-chloroadenine, 6-methylpurine, 8-azaadenine, 8-azaguanine, 1-deazaadenine, 3-deazaadenine, 1-(2-deoxy-β-D-ribofuranosyl) derivatives of 5-ethyluracil, 5-fluorouracil, and 9-(2,3-dideoxy-β-D-pentofuranosyl)hypoxanthine, 9-(2,3-dideoxy-β-D-pentofuranosyl)-6-methylpurine, and other nucleosides.

    藻酸盐凝胶包埋的辅助胸腺嘧啶依赖菌株大肠杆菌细胞催化2'-脱氧尿嘧啶的2-脱氧-D-核糖呋喃基团转移到嘌呤和嘧啶碱基以及它们的氮杂和去氮类似物。所有实验都不可避免地产生β-异构体;在大多数情况下,反应是区域特异性的,产生嘌呤中的N9-异构体和嘧啶系列中的N1-异构体。此外,2,3-二脱氧核苷酸可以作为糖基团的供体。嘌呤碱基的受体活性仅在取代上有少许影响,唯一的条件是存在N7-氮原子。另一方面,在嘧啶系列中,活性仅限于大多数短链5-烷基和5-卤代尿嘧啶衍生物的狭窄选择。含氨基的杂环碱基会发生脱氨作用;可以通过将碱基转化为相应的N-二甲氨基甲烯基衍生物来避免这种情况,然后进行氨解作用。该方法通过分离腺嘌呤、鸟嘌呤、2-氯腺嘌呤、6-甲基嘌呤、8-氮杂腺嘌呤、8-氮杂鸟嘌呤、1-去氮腺嘌呤、3-去氮腺嘌呤的9-(2-脱氧-β-D-核糖呋喃基)衍生物,5-乙基尿嘧啶、5-氟尿嘧啶的1-(2-脱氧-β-D-核糖呋喃基)衍生物,以及9-(2,3-二脱氧-β-D-戊呋喃基)缺氧嘌呤、9-(2,3-二脱氧-β-D-戊呋喃基)-6-甲基嘌呤和其他核苷酸的验证。
  • Imidazopyridine Derivatives
    申请人:Hirao Ichiro
    公开号:US20080125381A1
    公开(公告)日:2008-05-29
    The present invention relates to a novel imidazo[4,5-b]pyridine derivative compound represented by Formula (I) and a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the above compound. The present invention further relates to a pharmaceutical composition comprising the above compound. The above compound has growth inhibitory activity on cancer cells, and this effect is dissociated from growth inhibitory activity on normal cells. This indicates that the compound is useful as a novel anticancer agent.
    本发明涉及一种新型咪唑并[4,5-b]吡啶衍生物化合物,其表示为公式(I),以及其药学上可接受的盐。本发明还涉及制备上述化合物的方法。本发明还涉及包含上述化合物的制药组合物。上述化合物具有对癌细胞的生长抑制活性,且该效果与对正常细胞的生长抑制活性分离。这表明该化合物可用作新型抗癌剂。
  • IMIDAZOPYRIDINE DERIVATIVE
    申请人:Riken
    公开号:EP1847546B1
    公开(公告)日:2012-11-28
  • [Hg(9-methyl-1-deazapurine)2](NO3)2·H2O: a complex with a distorted hexagonal bipyramidal metal ion coordination sphere
    作者:Jens Müller、Fabian-Alexander Polonius、Michael Roitzsch
    DOI:10.1016/j.ica.2004.11.038
    日期:2005.3
    Reaction of 9-methyl-1-deazapurine (9-MeDP) with Hg(CF3COO)(2) in the presence of NaNO3 yields the title compound [Hg(9-MeDP)(2)](NO3)(2) center dot H2O with the two 9-MeDP ligands bound to the metal ion via their N7 positions. The X-ray structure is reported: monoclinic, P2(1)/c (no. 14), a = 5.4015(11), b = 20.467(4), c = 17.775(4) angstrom, beta = 97.00(3)degrees, V = 1950.4(7) angstrom(-3), Z = 4. Hg is eight-coordinate with two trans-oriented Hg-N bonds (2.073(3) and 2.075(3) angstrom) and three nearly coplanar, bidentate nitrate moieties (Hg-O: 2.716(3)-2.985(4) angstrom), leading to a distorted hexagonal bipyramidal environment of the metal ion. Within this structure, the nitrate ions form a honeycomb-like chain structure with Hg-II being positioned inside the combs. This work represents the first report of such geometry for a transition metal ion surrounded by symmetrically bidentate nitrate ions. The corresponding nucleoside, 1-deazapurine 2'-deoxyribonucleoside, also forms a stable 2:1 complex with Hg-II as was shown by H-1 NMR spectroscopy, making it a potential candidate for incorporation into nucleic acids based on metal-mediated base pairs. (c) 2004 Elsevier B.V. All rights reserved.
  • Efforts toward Expansion of the Genetic Alphabet:  Optimization of Interbase Hydrophobic Interactions
    作者:Yiqin Wu、Anthony K. Ogawa、Markus Berger、Dustin L. McMinn、Peter G. Schultz、Floyd E. Romesberg
    DOI:10.1021/ja0009931
    日期:2000.8.1
    Six novel unnatural nucleobases have been characterized that form stable base pairs in duplex DNA, relying nor on hydrogen bonds, but rather on interbase hydrophobic interactions. These nucleobases are derivatives of the hydrophobic base pair between 7-azaindole (7AI) and isocarbostyril (ICS). Derivatives of 7AI and ICS were examined that have increased hydrophobic surface area, as well as increased polarizability. As observed with 7AI and ICS, these derivatives are recognized as substrates by Klenow fragment of Escherichia coli DNA polymerase I. The unnatural base pair between pyrrolopyrizine (PP) and C3-methylisocarbostyril (MICS) is enzymatically incorporated into DNA with high efficiency (k(cat)/K-M = 10(6) M-1 min(-1)) and moderate selectivity. These studies represent a significant step toward the generation of astable, orthogonal base pair that can be enzymatically incorporated into DNA with good fidelity.
查看更多

同类化合物

阿法拉定A,TFA 钠(E)-2-氰基-3-[2,8-二(丙-2-基氧基)咪唑并[3,2-a]吡啶-3-基]丙-2-烯酸酯 诺白拉斯啶 苯酚,4-(5,6,7,8-四氢咪唑并[1,2-a]吡啶-8-基)- 米诺膦酸 米诺磷酸一水合物 硫酸利美戈潘 盐酸法屈唑半水合物 盐酸依格列汀 甲基咪唑并[1,5-A]吡啶-1-甲酸叔丁酯 甲基3-氨基咪唑并[1,2-a]吡啶-5-羧酸酯 甲基-(7-甲基咪唑并[1,2-A〕吡啶-2-基甲基)-胺 甲基-(5-甲基-咪唑并[1,2-A]吡啶-2-甲基)-胺 甲基 2-甲基咪唑并[1,2-a]吡啶-3-羧酸 环戊烷羧酸2-氨基-4-亚甲基-,(1R,2S)-(9CI) 环巴胺抑制剂1 泰妥拉唑 法倔唑盐酸盐 法倔唑 沃利替尼(对映异构体) 沃利替尼 氨基膦酸杂质14 巴马鲁唑 奥克塞米索 地扎胍宁甲磺酸盐 地扎胍宁 土大黄甙 咪唑磺隆 咪唑并吡啶-2-酮盐酸盐 咪唑并吡啶-2-酮 咪唑并二甲基吡啶 咪唑并[2,1-a]异喹啉-2(3H)-酮 咪唑并[1,5-a]吡啶-8-胺 咪唑并[1,5-a]吡啶-8-羧酸乙酯 咪唑并[1,5-a]吡啶-8-甲醛 咪唑并[1,5-a]吡啶-7-羧酸甲酯 咪唑并[1,5-a]吡啶-7-羧酸乙酯 咪唑并[1,5-a]吡啶-6-羧酸甲酯 咪唑并[1,5-a]吡啶-6-羧酸乙酯 咪唑并[1,5-a]吡啶-5-胺 咪唑并[1,5-a]吡啶-5-羧酸甲酯 咪唑并[1,5-a]吡啶-5-羧酸乙酯 咪唑并[1,5-a]吡啶-5-甲醛 咪唑并[1,5-a]吡啶-3-羧酸乙酯 咪唑并[1,5-a]吡啶-3-磺酰胺 咪唑并[1,5-a]吡啶-3-甲醛 咪唑并[1,5-a]吡啶-3(2H)-硫酮 咪唑并[1,5-a]吡啶-1-羧醛 咪唑并[1,5-a]吡啶-1-磺酰胺 咪唑并[1,5-a]吡啶-1-基-甲醇